Status:
COMPLETED
Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients
Lead Sponsor:
Benha University
Conditions:
COVID-19
Dysglycemia
Eligibility:
All Genders
20-65 years
Phase:
PHASE1
Brief Summary
Evaluation of the reciprocal relation between hyperglycemia/diabetes mellitus (HG/DM) and COVID-19 disease and the effect of mode of insulin therapy; intensive (IIT) or conventional (CIT) on patients'...
Detailed Description
All patients admitted to the quarantine department at Benha University hospital and quarantine hospitals all over the Qalyubia Governorate were eligible for evaluation for exclusion criteria. Taking o...
Eligibility Criteria
Inclusion
- Diabetic
- Non-diabetic
- Confirmed COVID-19 disease both by PCR diagnosis of viral RNA and by CT diagnosis of COVID- associated pneumonia.
Exclusion
- Patients younger than 18 years,
- Patients admitted with critical illness requiring immediate admission to ICU,
- Patients deceased before evaluation,
- Patients who had autoimmune diseases or were maintained on immunosuppressive therapy,
- Patients with chronic medical diseases other than DM,
- Patients requiring surgical interference for emergency conditions, and
- Patients who had cancer or were maintained anticancer therapy were excluded from the study.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
436 Patients enrolled
Trial Details
Trial ID
NCT05441631
Start Date
April 1 2020
End Date
December 1 2021
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Banha University
Banhā, El- Qalyobia, Egypt, 13511